{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:41:52Z","timestamp":1790674912595,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T00:00:00Z","timestamp":1405900800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2261-14-88","type":"journal-article","created":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T05:01:11Z","timestamp":1405918871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Effective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"14","author":[{"given":"Ruiping","family":"Shang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,21]]},"reference":[{"issue":"6","key":"861_CR1","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/eurheartj\/ehq030","volume":"31","author":"BJ Gersh","year":"2010","unstructured":"Gersh BJ, Sliwa K, Mayosi BM, Yusuf S: Novel therapeutic concepts. The epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J. 2010, 31 (6): 642-648. 10.1093\/eurheartj\/ehq030.","journal-title":"Eur Heart J"},{"issue":"8","key":"861_CR2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","volume":"123","author":"PA Heidenreich","year":"2011","unstructured":"Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Woo YJ: Forecasting the future of cardiovascular disease in the United States a policy statement from the American heart association. Circulation. 2011, 123 (8): 933-944. 10.1161\/CIR.0b013e31820a55f5.","journal-title":"Circulation"},{"issue":"9798","key":"861_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","volume":"378","author":"S Yusuf","year":"2011","unstructured":"Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, Teo KK: Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011, 378 (9798): 1231-1243. 10.1016\/S0140-6736(11)61215-4.","journal-title":"Lancet"},{"key":"861_CR4","volume-title":"Review Role of carnitine in disease","author":"JL Flanagan","year":"2010","unstructured":"Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q: Review Role of carnitine in disease. 2010"},{"key":"861_CR5","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1067\/mhj.2000.103918","volume":"139","author":"P Colonna","year":"2000","unstructured":"Colonna P, Iliceto S: Myocardial infarction and left ventricular remodeling: results of the CEDIM trial. Carnitine Ecocardiografia Digitalizzata Infarto Miocardico. Am Heart J. 2000, 139: S124-S130. 10.1067\/mhj.2000.103918.","journal-title":"Am Heart J"},{"key":"861_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10557-007-6056-9","volume":"21","author":"YZ Xue","year":"2007","unstructured":"Xue YZ, Wang LX, Liu HZ, Qi XW, Wang XH, Ren HZ: L-carnitine as an adjunct therapy to percutaneous coronary intervention for non-ST elevation myocardial infarction. Cardiovasc Drugs Ther. 2007, 21: 445-448. 10.1007\/s10557-007-6056-9.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"6","key":"861_CR7","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1016\/j.mayocp.2013.02.007","volume":"88","author":"JJ DiNicolantonio","year":"2013","unstructured":"DiNicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O\u2019Keefe JH: L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clinic Proc. 2013, 88 (6): 5444-51.","journal-title":"Mayo Clinic Proc"},{"issue":"1","key":"861_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1196\/annals.1320.003","volume":"1033","author":"CJ Rebouche","year":"2004","unstructured":"Rebouche CJ: Kinetics, pharmacokinetics, and regulation of l\u2012carnitine and acetyl\u2012l\u2012carnitine metabolism. Ann N Y Acad Sci. 2004, 1033 (1): 30-41. 10.1196\/annals.1320.003.","journal-title":"Ann N Y Acad Sci"},{"key":"861_CR9","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009, 339: b2700-10.1136\/bmj.b2700.","journal-title":"BMJ"},{"issue":"1","key":"861_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996, 17 (1): 1-12. 10.1016\/0197-2456(95)00134-4.","journal-title":"Control Clin Trials"},{"key":"861_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/9780470712184","volume-title":"Cochran Handbook for Systematic Review of Interventions: Assessing Risk of Bias in Included Studies","author":"JP Higgins","year":"2008","unstructured":"Higgins JP, Green S: Cochran Handbook for Systematic Review of Interventions: Assessing Risk of Bias in Included Studies. 2008, Hoboken, NJ: John Wiley & Sons Inc, 500","edition":"500"},{"issue":"8","key":"861_CR12","first-page":"355","volume":"18","author":"P Davini","year":"1992","unstructured":"Davini P, Bigalli A, Lamanna F, Boem A: Controlled study on L-carnitine therapeutic efficacy in post-infarction. Drugs Exp Clin Res. 1992, 18 (8): 355-365. PubMed PMID: 1292918. Epub 1992\/01\/01. eng","journal-title":"Drugs Exp Clin Res"},{"issue":"2","key":"861_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/0735-1097(95)80010-E","volume":"26","author":"S Iliceto","year":"1995","unstructured":"Iliceto S, Scrutinio D, Bruzzi P, D'Ambrosio G, Boni L, Di Biase M, Biasco G, Hugenholtz PG, Rizzon P: Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. J Am Coll Cardiol. 1995, 26 (2): 380-387. 10.1016\/0735-1097(95)80010-E. PubMed PMID: 7608438. Epub 1995\/08\/01. eng","journal-title":"J Am Coll Cardiol"},{"issue":"843","key":"861_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/pgmj.72.843.45","volume":"72","author":"RB Singh","year":"1996","unstructured":"Singh RB, Niaz MA, Agarwal P, Beegum R, Rastogi SS, Sachan DS: A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction. Postgrad Med J. 1996, 72 (843): 45-50. 10.1136\/pgmj.72.843.45. PubMed PMID: 8746285. Pubmed Central PMCID: 2398308. Epub 1996\/01\/01. eng","journal-title":"Postgrad Med J"},{"issue":"2","key":"861_CR15","first-page":"38","volume":"45","author":"R Iyer","year":"1999","unstructured":"Iyer R, Gupta A, Khan A, Hiremath S, Lokhandwala Y: Does left ventricular function improve with L-carnitine after acute myocardial infarction?. J Postgrad Med. 1999, 45 (2): 38-41. PubMed PMID: 10734331. Epub 2000\/03\/29. eng","journal-title":"J Postgrad Med"},{"issue":"4","key":"861_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000093131","volume":"106","author":"G Tarantini","year":"2006","unstructured":"Tarantini G, Scrutinio D, Bruzzi P, Boni L, Rizzon P, Iliceto S: Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial. Cardiology. 2006, 106 (4): 215-223. 10.1159\/000093131. PubMed PMID: 16685128. Epub 2006\/05\/11. eng","journal-title":"Cardiology"},{"issue":"11","key":"861_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2165\/00003088-200342110-00002","volume":"42","author":"AM Evans","year":"2003","unstructured":"Evans AM, Fornasini G: Pharmacokinetics of L-carnitine. Clin Pharmacokinet. 2003, 42 (11): 941-967. 10.2165\/00003088-200342110-00002.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"861_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL: Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013, 19 (5): 576-585. 10.1038\/nm.3145.","journal-title":"Nat Med"},{"issue":"4","key":"861_CR19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jn\/121.4.539","volume":"121","author":"CJ Rebouche","year":"1991","unstructured":"Rebouche CJ, Chenard CA: Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites. J Nutr. 1991, 121 (4): 539-546.","journal-title":"J Nutr"},{"issue":"1","key":"861_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","volume":"17","author":"BJ Bennett","year":"2013","unstructured":"Bennett BJ, Vallim TQ, Wang Z, Shih DM, Meng Y, Gregory J, Allayee H, Lee R, Graham M, Crooke R, Edwards PA, Hazen SL, Lusis AJ: Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013, 17 (1): 49-60. 10.1016\/j.cmet.2012.12.011.","journal-title":"Cell Metab"},{"issue":"17","key":"861_CR21","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL: Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013, 368 (17): 1575-1584. 10.1056\/NEJMoa1109400.","journal-title":"N Engl J Med"},{"issue":"11","key":"861_CR22","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1073\/pnas.1316569111","volume":"111","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Jameson E, Crosatti M, Sch\u00e4fer H, Rajakumar K, Bugg TD, Chen Y: Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci. 2014, 111 (11): 4268-4273. 10.1073\/pnas.1316569111.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"861_CR23","doi-asserted-by":"crossref","first-page":"618s","DOI":"10.1093\/ajcn\/72.2.618S","volume":"72","author":"EP Brass","year":"2000","unstructured":"Brass EP: Supplemental carnitine and exercise. Am J Clin Nutr. 2000, 72 (2): 618s-623s.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"861_CR24","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1172\/JCI117488","volume":"94","author":"R Friolet","year":"1994","unstructured":"Friolet R, Hoppeler H, Kr\u00e4henb\u00fchl S: Relationship between the coenzyme A and the carnitine pools in human skeletal muscle at rest and after exhaustive exercise under normoxic and acutely hypoxic conditions. J Clin Investig. 1994, 94 (4): 1490-10.1172\/JCI117488.","journal-title":"J Clin Investig"},{"issue":"1","key":"861_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0014-5793(94)80246-7","volume":"341","author":"J Arenas","year":"1994","unstructured":"Arenas J, Huertas R, Campos Y, D\u00edaz AE, Villal\u00f3n JM, Vilas E: Effects of L-carnitine on the pyruvate dehydrogenase complex and carnitine palmitoyl transferase activities in muscle of endurance athletes. FEBS Lett. 1994, 341 (1): 91-93. 10.1016\/0014-5793(94)80246-7.","journal-title":"FEBS Lett"},{"issue":"1","key":"861_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/0006-291X(92)92355-2","volume":"188","author":"R Huertas","year":"1992","unstructured":"Huertas R, Campos Y, D\u00edaz E, Esteban J, Vechietti L, Montanari G, D'Iddio S, Corsi M, Arenas J: Respiratory chain enzymes in muscle of endurance athletes: effect of L-carnitine. Biochem Biophys Res Commun. 1992, 188 (1): 102-107. 10.1016\/0006-291X(92)92355-2.","journal-title":"Biochem Biophys Res Commun"},{"issue":"18","key":"861_CR27","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1113\/jphysiol.2013.255364","volume":"591","author":"FB Stephens","year":"2013","unstructured":"Stephens FB, Wall BT, Marimuthu K, Shannon CE, Constantin\u2012Teodosiu D, Macdonald IA, Greenhaff PL: Skeletal muscle carnitine loading increases energy expenditure, modulates fuel metabolism gene networks and prevents body fat accumulation in humans. J Physiol. 2013, 591 (18): 4655-4666. 10.1113\/jphysiol.2013.255364.","journal-title":"J Physiol"},{"issue":"4","key":"861_CR28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1113\/jphysiol.2010.201343","volume":"589","author":"BT Wall","year":"2011","unstructured":"Wall BT, Stephens FB, Constantin\u2012Teodosiu D, Marimuthu K, Macdonald IA, Greenhaff PL: Chronic oral ingestion of l\u2012carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. J Physiol. 2011, 589 (4): 963-973. 10.1113\/jphysiol.2010.201343.","journal-title":"J Physiol"},{"issue":"2","key":"861_CR29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1096\/fj.05-4985fje","volume":"20","author":"FB Stephens","year":"2006","unstructured":"Stephens FB, Constantin-Teodosiu D, Laithwaite D, Simpson EJ, Greenhaff PL: Insulin stimulates L-carnitine accumulation in human skeletal muscle. FASEB J. 2006, 20 (2): 377-379.","journal-title":"FASEB J"},{"issue":"5","key":"861_CR30","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.ijcard.2012.04.150","volume":"167","author":"T Ueland","year":"2013","unstructured":"Ueland T, Svardal A, \u00d8ie E, Askevold ET, Nymoen SH, Bj\u00f8rndal B, Dahl CP, Gullestad L, Berge RK, Aukrust P: Disturbed carnitine regulation in chronic heart failure\u2014increased plasma levels of palmitoyl-carnitine are associated with poor prognosis. Int J Cardiol. 2013, 167 (5): 1892-1899. 10.1016\/j.ijcard.2012.04.150.","journal-title":"Int J Cardiol"},{"issue":"2 suppl","key":"861_CR31","doi-asserted-by":"crossref","first-page":"2S8","DOI":"10.1177\/0883073895010002S03","volume":"10","author":"R Pons","year":"1995","unstructured":"Pons R, Darryl C: Primary and secondary carnitine deficiency syndromes. J Child Neurol. 1995, 10 (2 suppl): 2S8-2S24.","journal-title":"J Child Neurol"},{"key":"861_CR32","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/S0272-6386(03)00113-6","volume":"41","author":"A Evans","year":"2003","unstructured":"Evans A: Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis. 2003, 41: S13-S26.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-88.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-14-88\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-88","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-88.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T15:59:53Z","timestamp":1548172793000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-14-88"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,21]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-14-88","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,21]]},"assertion":[{"value":"11 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"88"}}